View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Cardiometabolic Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 24, 2022
3 min read
Save

Reversing CVD trends requires focus on health equity, early interventions

Reversing CVD trends requires focus on health equity, early interventions

PHILADELPHIA — CVD trends, particularly for HF, have gotten worse since 2011, and a way to address them may be to focus on health equity and begin prevention early, a speaker said at the Heart in Diabetes CME conference.

SPONSORED CONTENT
June 24, 2022
2 min read
Save

Black patients with HF undertreated with SGLT2 inhibitors

Black patients with HF undertreated with SGLT2 inhibitors

PHILADELPHIA — Black patients are highly likely to benefit from prescription of SGLT2 inhibitors for HF, but they are less commonly prescribed them compared with other patients, according to a speaker.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
June 24, 2022
2 min read
Save

Black patients with HF undertreated with SGLT2 inhibitors

Black patients with HF undertreated with SGLT2 inhibitors

PHILADELPHIA — Black patients are highly likely to benefit from prescription of SGLT2 inhibitors for HF, but they are less commonly prescribed them compared with other patients, according to a speaker.

SPONSORED CONTENT
June 23, 2022
3 min read
Save

Hybrid Heart in Diabetes conference offers ‘new twist’ on latest cardiometabolic research

Hybrid Heart in Diabetes conference offers ‘new twist’ on latest cardiometabolic research

Experts across the cardiorenal metabolic specialties will again convene to present innovative research on the relationship between type 2 diabetes, CVD and renal disease, including controversial debates and panel discussions.

SPONSORED CONTENT
June 23, 2022
1 min read
Save

Thyroid hormone levels linked to liver fibrosis in type 2 diabetes

Thyroid hormone levels linked to liver fibrosis in type 2 diabetes

Among patients with type 2 diabetes and normal thyroid function, thyroid hormone levels were linked to nonalcoholic fatty liver disease, suggesting assessment of these hormones might be beneficial for disease prevention and treatment.

SPONSORED CONTENT
June 23, 2022
2 min read
Save

Growth hormone reduces liver fat, inflammation in adults with NAFLD

Growth hormone reduces liver fat, inflammation in adults with NAFLD

ATLANTA — Adults with overweight or obesity and nonalcoholic fatty liver disease, or NAFLD, had a significant reduction in liver fat and inflammation with daily subcutaneous growth hormone administration, according to a speaker.

SPONSORED CONTENT
June 22, 2022
2 min read
Save

Lower HbA1c, blood pressure protect against CVD in type 1 diabetes

Lower HbA1c, blood pressure protect against CVD in type 1 diabetes

Both lower HbA1c and lower blood pressure were protective cardiovascular health metrics for adults with type 1 diabetes, according to findings published in Diabetologia.

SPONSORED CONTENT
June 17, 2022
2 min read
Save

Endocrine-disrupting chemicals elevate risk for gestational diabetes

Endocrine-disrupting chemicals elevate risk for gestational diabetes

Exposure to certain endocrine-disrupting chemicals, including polychlorinated biphenyls and polybrominated diphenyl ethers, heightened the risk for gestational diabetes in a recent study.

SPONSORED CONTENT
June 14, 2022
2 min read
Save

Empagliflozin lowers risk for kidney stones in type 2 diabetes

Empagliflozin lowers risk for kidney stones in type 2 diabetes

ATLANTA — Use of empagliflozin was associated with a nearly 40% reduced risk for nephrolithiasis among people with type 2 diabetes, according to data presented at ENDO 2022.

SPONSORED CONTENT
June 14, 2022
2 min read
Save

SGLT2 inhibition may improve CV outcomes in those with diabetes undergoing cancer therapy

SGLT2 inhibition may improve CV outcomes in those with diabetes undergoing cancer therapy

In patients with diabetes and cancer treated with anthracyclines, SGLT2 inhibition was associated with fewer cardiac events during 1.5 years of follow-up, researchers reported.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails